Sule Ari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sule Ari has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Özgür Çakır
Istanbul University, Faculty of Science, Department of Molecular Biology and Genetics, Istanbul, Türkiye
4 shared publications - Neslihan Turgut Kara
Istanbul University, Faculty of Science, Department of Molecular Biology and Genetics, Istanbul, Türkiye
3 shared publications - Sinan Meriç
Faculty of Science and Letters, Molecular Biology and Genetics, Istanbul Kültür University, Istanbul 34158, Türkiye
3 shared publications - Ahmet Dogan
Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Istanbul, Turkey
2 shared publications - Baki Yaman
Istanbul Univ, Fac Sci, Dept Mol Biol & Genet, Istanbul, Turkiye
2 shared publications - Elif Karlik
İstinye University
2 shared publications
Latest Publications
- 5 March 2026
- Published by Springer Nature in Plant Biosystems
- Vol. 160 (3)
Efficient in vitro propagation protocol for hazelnut (Corylus avellana) via zygotic embryo
- 5 March 2026
- Published by Springer Nature in Plant Biosystems
- Vol. 160 (3)
Efficient in vitro propagation protocol for hazelnut (Corylus avellana) via zygotic embryo
- 17 September 2025
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 163 (1) , 1-10
Synergistic effects of methyl-β-cyclodextrin and coronatine on biomass accumulation and taxane secretion in Corylus avellana L. cell suspension cultures
- 17 September 2025
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 163 (1) , 1-10
Synergistic effects of methyl-β-cyclodextrin and coronatine on biomass accumulation and taxane secretion in Corylus avellana L. cell suspension cultures
- 18 April 2025
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 61 (2) , 302-311
Efficient Cloning and Expression of IsPETase in the E. coli SHuffle Cells; Activity Analysis using HR-LC/MS
Polyethylene terephthalate (PET), a highly persistent and challenging-to-recycle material, poses a very concerning threat to the environment due to is over accumulation. To combat this issue, we focus on PETase, a biomolecule with immense potential for PET recycling due to its exceptional activity and substrate specificity compared to other PET-degrading enzymes. In this study, the overexpression of IsPETase from Ideonella sakaiensis, was investigated by optimizing its codon usage, cloning it into the pET plasmid, and successfully expressing it in the cytoplasm of Escherichia coli using SHuffle cells, which facilitate the expression of proteins requiring disulfide bonds for proper folding and functionality. Under the optimized conditions, the Shuffle expression system yielded an average of 69.3 mg of IsPETase, with an uncertainty of ±16.8 mg (n = 3), in 1-L culture. This represents an impressive 11.5-fold increase compared to its conventional expression in E. coli. After production, we confirmed the identity of the PETase enzyme using a bottom-up proteomics approach, achieving an impressive 97% coverage and identifying 21 unique peptides. Our research findings were strengthened through additional investigations utilizing High-Resolution Liquid Chromatography-Mass Spectrometry (HR-LC/MS) and Scanning Electron Microscopy (SEM). These analyses confirmed the active production of the PETase in the E. coli SHuffle cells, and its effective PET depolymerization. The application of HR-LC/MS allowed us to quantitatively monitor PETase activity, providing a distinctive approach for future PET recycling and enzyme engineering studies. Overall, our research presents a promising solution to the efficient production of active IsPETase enzyme.
- 18 April 2025
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 61 (2) , 302-311
Efficient Cloning and Expression of IsPETase in the E. coli SHuffle Cells; Activity Analysis using HR-LC/MS
Polyethylene terephthalate (PET), a highly persistent and challenging-to-recycle material, poses a very concerning threat to the environment due to is over accumulation. To combat this issue, we focus on PETase, a biomolecule with immense potential for PET recycling due to its exceptional activity and substrate specificity compared to other PET-degrading enzymes. In this study, the overexpression of IsPETase from Ideonella sakaiensis, was investigated by optimizing its codon usage, cloning it into the pET plasmid, and successfully expressing it in the cytoplasm of Escherichia coli using SHuffle cells, which facilitate the expression of proteins requiring disulfide bonds for proper folding and functionality. Under the optimized conditions, the Shuffle expression system yielded an average of 69.3 mg of IsPETase, with an uncertainty of ±16.8 mg (n = 3), in 1-L culture. This represents an impressive 11.5-fold increase compared to its conventional expression in E. coli. After production, we confirmed the identity of the PETase enzyme using a bottom-up proteomics approach, achieving an impressive 97% coverage and identifying 21 unique peptides. Our research findings were strengthened through additional investigations utilizing High-Resolution Liquid Chromatography-Mass Spectrometry (HR-LC/MS) and Scanning Electron Microscopy (SEM). These analyses confirmed the active production of the PETase in the E. coli SHuffle cells, and its effective PET depolymerization. The application of HR-LC/MS allowed us to quantitatively monitor PETase activity, providing a distinctive approach for future PET recycling and enzyme engineering studies. Overall, our research presents a promising solution to the efficient production of active IsPETase enzyme.
- Open Access
- 27 November 2024
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70 (11) , 89-94
Antiproliferative effects of hazelnut cell culture extract on the different cancer cell lines
The increasing incidence of cancer has necessitated the discovery of novel anticancer compound sources. The presence of taxanes in hazelnut cell cultures has promoted new promising pharmacotherapeutic applications. The antiproliferative properties of hazelnut (Corylus avellana cv. 'Kalınkara') cell culture extracts against different human cancer cell lines (HeLa, MCF-7, MDA-MB-231, A549) with Beas-2B as control were evaluated. The cytotoxicity of C. avellana culture extract (5 µM, 10 µM, and 20 µM) on all cell lines was evaluated with xCELLigence Real Time Cell Analysis System. Mitotic activity (450-655 nm), BrdU activity (450-550 nm) and caspase 3,7 activity (490-520 nm) were analyzed with a spectrophotometer through 24, 48, and 72 hours. Based on the values obtained from the xCELLigence Cell Analysis System, a 10 µM concentration of the culture extract was assigned as the IC50 dose. Culture extracts at 10 µM enhanced the reduction in the proliferation of all cancer cells assayed. The highest decrease in mitotic (59.32%) and BrdU (53.77%) activity was observed in A549 lung cancer cells. However, caspase 3,7 activity (35.08%) was the highest in aggressive MDA-MB-231 breast cancer cells. The culture extracts decreased the viability of A549 cells to a greater extent than that of MCF-7 and MDA-MB-231 breast, and HeLa cervical cancer cells. C. avellana cv. 'Kalınkara' cell culture extracts have potential use in the treatment of lung and, to a lesser extent, breast and cervical cancers.
- 27 November 2024
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70 (11) , 89-94
Open AccessAntiproliferative effects of hazelnut cell culture extract on the different cancer cell lines
The increasing incidence of cancer has necessitated the discovery of novel anticancer compound sources. The presence of taxanes in hazelnut cell cultures has promoted new promising pharmacotherapeutic applications. The antiproliferative properties of hazelnut (Corylus avellana cv. 'Kalınkara') cell culture extracts against different human cancer cell lines (HeLa, MCF-7, MDA-MB-231, A549) with Beas-2B as control were evaluated. The cytotoxicity of C. avellana culture extract (5 µM, 10 µM, and 20 µM) on all cell lines was evaluated with xCELLigence Real Time Cell Analysis System. Mitotic activity (450-655 nm), BrdU activity (450-550 nm) and caspase 3,7 activity (490-520 nm) were analyzed with a spectrophotometer through 24, 48, and 72 hours. Based on the values obtained from the xCELLigence Cell Analysis System, a 10 µM concentration of the culture extract was assigned as the IC50 dose. Culture extracts at 10 µM enhanced the reduction in the proliferation of all cancer cells assayed. The highest decrease in mitotic (59.32%) and BrdU (53.77%) activity was observed in A549 lung cancer cells. However, caspase 3,7 activity (35.08%) was the highest in aggressive MDA-MB-231 breast cancer cells. The culture extracts decreased the viability of A549 cells to a greater extent than that of MCF-7 and MDA-MB-231 breast, and HeLa cervical cancer cells. C. avellana cv. 'Kalınkara' cell culture extracts have potential use in the treatment of lung and, to a lesser extent, breast and cervical cancers.
- Open Access
- 9 January 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (4) , 367-375
Analysis of anticancer taxanes in Turkish hazelnut (Corylus avellana L.) genotypes by high-performance liquid chromatography
Objectives: This study aimed to investigate the anticancer taxane profiles of edible and non-edible parts of seven Turkish hazelnut ( Corylus avellana L.) genotypes. Hazelnut is one of the healthy foods rich in nutrients and antioxidants. Its regular consumption is associated with a reduced risk of coronary heart disease and cancer. Hazelnut has been described as a plant source that produces taxanes which are widely used in many cancers. Turkiye is a homeland of hazelnut culture and has its own cultivars. Investigation of anticancer taxane profiles in different parts of Turkish hazelnut genotypes is important to show the potential and value of this plant from the perspective of the pharmaceutical and food industries. Materials and Methods: In this study, green leafy covers (GLCs) and hard shells (HSs) (non-edible parts), skinless kernels (SKs), brown-skins (BSs), and brown-skinned kernels (BSKs) (edible parts) of & Ccedil;ak & imath;ldak, Sivri, Tombul, Palaz, and Kal & imath;nkara as standard and Ham and Sivri Ya & gbreve;l & imath; as local genotypes were used. The five parts of each genotype were ground to powder and eliminated to a size of less than 80 mesh. Each part was extracted using hexane and methanol for 10-deacetylbaccatin III (10-DAB III), baccatin III (BAC III), cephalomannine, and paclitaxel analyses in three replicates. Samples and standards were analyzed by acetonitrile: water gradient method on NOVA Spher 100 Phenyl-Hexyl C18 column inhighperformance liquid chromatography reverse phase system with 228 nm ultraviolet detector and 1.0 mL/min flow rate. Microsoft Office Excel, 2016, and analysis of variance Jamovi Version 2.3 were used for statistical and data analysis, consecutively. Results: Hazelnut parts differed to a very high degree from each other in terms of the highest amount of 10- DAB III (Ham HSs, 9,15 mu g/g), BAC III (Kal & imath;nkara BSs, 7.24 mu g/g), cephalomannine (Sivri Ya & gbreve;l & imath; BSs, 6.37 mu g/g), and paclitaxel (Ham BSKs, 4.36 mu g/g) they contained. While HSs, BSKs, and BSs were rich in taxanes in all of the analyzed genotypes, SKs, and GLCs remain limited for anticancer taxanes. Conclusion: This is the first report that revealed the differences in taxane contents of Turkish hazelnuts including previously untested standard and local genotypes and their parts. Significant differences between genotype and hazelnut parts are expected to highlight the health benefits of consuming raw Turkish hazelnut with BSs and their possible use as a functional food. These results add more information to elucidate the bioactive potential of Turkish hazelnuts and their by-products and provide a promising resource for the food and pharmaceutical industry with an anticancer perspective.
- 9 January 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (4) , 367-375
Open AccessAnalysis of anticancer taxanes in Turkish hazelnut (Corylus avellana L.) genotypes by high-performance liquid chromatography
Objectives: This study aimed to investigate the anticancer taxane profiles of edible and non-edible parts of seven Turkish hazelnut ( Corylus avellana L.) genotypes. Hazelnut is one of the healthy foods rich in nutrients and antioxidants. Its regular consumption is associated with a reduced risk of coronary heart disease and cancer. Hazelnut has been described as a plant source that produces taxanes which are widely used in many cancers. Turkiye is a homeland of hazelnut culture and has its own cultivars. Investigation of anticancer taxane profiles in different parts of Turkish hazelnut genotypes is important to show the potential and value of this plant from the perspective of the pharmaceutical and food industries. Materials and Methods: In this study, green leafy covers (GLCs) and hard shells (HSs) (non-edible parts), skinless kernels (SKs), brown-skins (BSs), and brown-skinned kernels (BSKs) (edible parts) of & Ccedil;ak & imath;ldak, Sivri, Tombul, Palaz, and Kal & imath;nkara as standard and Ham and Sivri Ya & gbreve;l & imath; as local genotypes were used. The five parts of each genotype were ground to powder and eliminated to a size of less than 80 mesh. Each part was extracted using hexane and methanol for 10-deacetylbaccatin III (10-DAB III), baccatin III (BAC III), cephalomannine, and paclitaxel analyses in three replicates. Samples and standards were analyzed by acetonitrile: water gradient method on NOVA Spher 100 Phenyl-Hexyl C18 column inhighperformance liquid chromatography reverse phase system with 228 nm ultraviolet detector and 1.0 mL/min flow rate. Microsoft Office Excel, 2016, and analysis of variance Jamovi Version 2.3 were used for statistical and data analysis, consecutively. Results: Hazelnut parts differed to a very high degree from each other in terms of the highest amount of 10- DAB III (Ham HSs, 9,15 mu g/g), BAC III (Kal & imath;nkara BSs, 7.24 mu g/g), cephalomannine (Sivri Ya & gbreve;l & imath; BSs, 6.37 mu g/g), and paclitaxel (Ham BSKs, 4.36 mu g/g) they contained. While HSs, BSKs, and BSs were rich in taxanes in all of the analyzed genotypes, SKs, and GLCs remain limited for anticancer taxanes. Conclusion: This is the first report that revealed the differences in taxane contents of Turkish hazelnuts including previously untested standard and local genotypes and their parts. Significant differences between genotype and hazelnut parts are expected to highlight the health benefits of consuming raw Turkish hazelnut with BSs and their possible use as a functional food. These results add more information to elucidate the bioactive potential of Turkish hazelnuts and their by-products and provide a promising resource for the food and pharmaceutical industry with an anticancer perspective.
- 13 March 2023
- Published by Springer Nature in Genetic Resources and Crop Evolution
- Vol. 70 (7) , 2077-2095
Profile-based proteomic investigation of unintended effects on transgenic and gamma radiation induced mutant soybean plants
- 13 March 2023
- Published by Springer Nature in Genetic Resources and Crop Evolution
- Vol. 70 (7) , 2077-2095
Profile-based proteomic investigation of unintended effects on transgenic and gamma radiation induced mutant soybean plants
- Open Access
- 10 March 2023
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 37 (1)
Enhancement of taxane production in cell suspension culture of Corylus avellana L. Kalınkara by elicitation and precursor feeding
- 10 March 2023
- Published by Taylor & Francis in Biotechnology & Biotechnological Equipment
- Vol. 37 (1)
Open AccessEnhancement of taxane production in cell suspension culture of Corylus avellana L. Kalınkara by elicitation and precursor feeding
- 9 April 2020
- Published by Springer Nature in Genetic Resources and Crop Evolution
- Vol. 67 (6) , 1551-1566
Genome organization changes in GM and non-GM soybean [Glycine max (L.) Merr.] under salinity stress by retro-transposition events
- 9 April 2020
- Published by Springer Nature in Genetic Resources and Crop Evolution
- Vol. 67 (6) , 1551-1566
Genome organization changes in GM and non-GM soybean [Glycine max (L.) Merr.] under salinity stress by retro-transposition events
- 8 April 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (5) , 519-528
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting the bromodomains of coactivators CREB (cyclic-AMP response element binding protein) binding protein (CBP) and E1A binding protein of 300 kDa (EP300) as potent enhancers of reprogramming. These inhibitors accelerate reprogramming, are critical during its early stages and, when combined with DOT1L inhibition, enable efficient derivation of human induced pluripotent stem cells (iPSCs) with OCT4 and SOX2. In contrast, catalytic inhibition of CBP/EP300 prevents iPSC formation, suggesting distinct functions for different coactivator domains in reprogramming. CBP/EP300 bromodomain inhibition decreases somatic-specific gene expression, histone H3 lysine 27 acetylation (H3K27Ac) and chromatin accessibility at target promoters and enhancers. The master mesenchymal transcription factor PRRX1 is one such functionally important target of CBP/EP300 bromodomain inhibition. Collectively, these results show that CBP/EP300 bromodomains sustain cell-type-specific gene expression and maintain cell identity.
- 8 April 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (5) , 519-528
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting the bromodomains of coactivators CREB (cyclic-AMP response element binding protein) binding protein (CBP) and E1A binding protein of 300 kDa (EP300) as potent enhancers of reprogramming. These inhibitors accelerate reprogramming, are critical during its early stages and, when combined with DOT1L inhibition, enable efficient derivation of human induced pluripotent stem cells (iPSCs) with OCT4 and SOX2. In contrast, catalytic inhibition of CBP/EP300 prevents iPSC formation, suggesting distinct functions for different coactivator domains in reprogramming. CBP/EP300 bromodomain inhibition decreases somatic-specific gene expression, histone H3 lysine 27 acetylation (H3K27Ac) and chromatin accessibility at target promoters and enhancers. The master mesenchymal transcription factor PRRX1 is one such functionally important target of CBP/EP300 bromodomain inhibition. Collectively, these results show that CBP/EP300 bromodomains sustain cell-type-specific gene expression and maintain cell identity.